 Home > Active Ingredient News > Study of Nervous System > SLEEP 2020: AXS-12 (reboxetine) treats narcolepsy, Phase II trial results to be announced.

SLEEP 2020: AXS-12 (reboxetine) treats narcolepsy, Phase II trial results to be announced.

 Last Update: 2020-09-25
 Source: Internet
 Author: User

Tags

fda approved sunscreen

naloxone drug class

what drug monograph

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Hypersomnia is an oversleeping disorder with two main types: primary narcolepsy and recurrent narcolepsy.
narcolepsy may be caused by brain damage or severe depressive disorders, uremia and fibromyalgia.
may also be a symptom of sleep disorders such as sleep apnea, sleep apnea, sleep foot movements, and periodic limb movements.
also lead to narcolepsy, such as taking certain medications (some psychotic drugs) or alcohol abuse.
, a biopharmaceutical company dedicated to developing new treatments for central nervous system (CNS) disease, announced today that it will publish data on the effectiveness and safety of AXS-12 for narcolepsy at the 2020 Sleep Conference (SLEEP 2020).
AXS-12 (reboxetine) is a highly selective dethynephrine reuptake inhibitor used to treat narcolepia.
AXS-12 regulates epinephrine activity to promote sobriety, maintain muscle dystas and enhance cognitive ability.
AXS-12 has been awarded the U.S. Food and Drug Administration's (FDA) breakthrough therapy title and orphan drug title for the treatment of narcolepsy.
AXS-12 is still a research compound that has not been approved by the FDA.
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin (CNS)

CAS No.: 148553-50-8

Pharmacy Grade

$1/KG FOB

Primidone CAS125-33-7

CAS No.: 125-33-7

Pharmaceutical Grade

$100/KG EXW

API Clomipramine HCl

CAS No.: 17321-77-6

Pharmacy Grade

$40-50/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.